News Posts List
Argos Therapeutics Enrolls Initial Patients in Pivotal Phase 3 ADAPT Study
01/23/2013
AGS-003, first fully personalized, dendritic-based immunotherapy being evaluated in combination with targeted therapy for mRCC.
Amgen Gets a Gift From Congress
01/23/2013
For a disheartening example of how intense lobbying and financial contributions can distort the legislative process in Washington, consider what happened to the “fiscal cliff” bill approved three weeks ago by Congress.
Rice-Cell Cocktail Tough On Cancer Cells, Nice to Normal Cells
01/23/2013
After 96 hours of exposure to a 20-to-1 rice callus solution, 95 percent of the kidney cancer cells were killed...
Aveo Pharma says it will sell $50M in stock
01/18/2013
Aveo Pharmaceuticals Inc. said Thursday it plans to sell about $50 million in stock.
Uplifting Athletes Rare Disease Champion Award
01/17/2013
A redshirt junior guard, Shrive has raised nearly $70,000 for the Kidney Cancer Association during his Penn State career.
IMA901 (Renal Cell Carcinoma) - Analysis and Forecasts to 2022 for US, EU5 and Japan
01/17/2013
The report also includes information on Renal Cell Carcinoma market.
Will 2008 Legislation Cause Drug Prices to Skyrocket?
01/15/2013
Many physicians have expressed concerns about how comparative effectiveness analysis will be used by payors and insurers.
Argos Therapeutics Enrolls Initial Patients in Pivotal Phase 3 ADAPT Study
01/15/2013
Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, announced that the first patients have been enrolled in the ADAPT Phase 3 clinical study for AGS-003, its most advanced product candidate.
Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma
01/15/2013
We aimed to evaluate the efficacy and safety of foretinib in patients with PRCC.
Issues pose challenge to closing minority health gap
01/14/2013
A deadline for eliminating disparities by 2010 has come and gone.
News Feed